CARsgen Therapeutics IPO Initiation: Choosing Therapies À La CAR-T
CARsgen is pre-marketing an HKEx IPO to raise proceeds of $400-500m. The promising prospects for the lead product, credible management and a good...
333 Views
Japan CAR-T Therapy Landscape
Japan CAR-T therapy - Competitive landscapeJapan pharma catching-up with global players… but a large gap remains Novartis AG (NOVN SE)’ Kymriah...
1.1k Views
Binex - Paving the Way for Next-Gen Biotech Breakthrough
We met with Mr. HJ Lee, CEO & President of Binex, followed by a quick site tour in Incheon, Korea, and learned that the company has recently...
333 Views
Kite Pharma: 'Flying Higher' in Red-Hot Cancer Immune-Oncology Space.
With the current pullback in its stock price, we are taking this opportunity to initiate a long position in Kite Pharma Inc (KITE US) , another...
401 Views